Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Recurrence 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Anus Neoplasms 1Anal Canal Carcinoma 1

Interventions

Cisplatin 32Radiotherapy, Intensity-Modulated 17Radiotherapy 17Carboplatin 14Radiation 11Magnetic Resonance Spectroscopy 10Cetuximab 8Specimen Handling 7Platinum 7Paclitaxel 71,2-diaminocyclohexaneplatinum II citrate 7Docetaxel 6Chemoradiotherapy 6Surgical Procedures, Operative 5pembrolizumab 4Nivolumab 4Celecoxib 4cemiplimab 3Taxes 3Surveys and Questionnaires 3Fluorouracil 3Drug Therapy 3toripalimab 2durvalumab 2aldesleukin 2X-Rays 2Standard of Care 2Restraint, Physical 2Observation 2Neck Dissection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Oropharyngeal Neoplasms × MEDI0457 × Clear all
NCT04001413 2022-07-29

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Head & Neck

Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡